Nanomik Biotechnology
Istanbul
About Nanomik Biotechnology
Nanomik Biotechnology is a next-generation biotechnology company building foundational technologies for sustainable biological protection across industries. The company’s patented Microcapsule Generation System (MGS®) is a proprietary biodegradable encapsulation platform that stabilizes, protects, and controls the release of natural molecules ’ transforming them into long-lasting, residue-free, and industrially scalable solutions. Designed for cross-sector adaptability, Nanomik’s base technology enables biological actives to perform reliably under diverse environmental and processing conditions. Its applications extend far beyond agriculture ’ powering innovation in crop protection, construction materials, food preservation, and specialty chemical industries. The company’s bio-based solutions are proven effective against mold, insects, and mites, addressing major durability and hygiene challenges in both natural and built environments. Nanomik’s strategic approach combines deep scientific expertise with regulatory agility. Operating from a geography that bridges advanced and emerging markets, the company benefits from internationally harmonized compliance frameworks that accelerate product validation and market access across multiple regions. This unique position allows Nanomik to scale biological technologies faster and more efficiently than traditional industry models. Backed by strategic industrial collaborations and international innovation programs, Nanomik has achieved >90% encapsulation efficiency, significant carbon footprint reduction, and robust intellectual property protection across its core platform. The company has completed a €1.25M post-seed funding round with milestone-based follow-up investment and is preparing for its Series A to expand manufacturing capacity and strengthen global commercialization. Nanomik’s vision is to redefine how biological actives are stabilized, delivered, and commercialized ’ enabling the world’s transition from synthetic chemistry to sustainable biology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $6.9M
- Funding stage: Early Stage Venture
- Last round: Grant (Aug 2025)
- Website: nanomik-tech.com
- Phone: +90 505-664-0402
Industries & Categories
AgTech, Biotechnology, Chemical, Construction, Life Science
Social Profiles
Canonical: https://fsome.com/organization/nanomik-biotechnology-94212 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.